CAS Number:
138199-71-0
Category:
Broad Spectrum Antibiotic
Regulatory Status:
CEP Approved
regulatory_status
CEP/EDMF:
CEP [R0-CEP 2019-315-Rev 00]
Innovator Brand:
Levaquin, Quinsair
Therapeutic Area:
Anti-Infective
USDMF:
-
Others:
Filed in Greece & Bulgaria
Mechanism of Action
Levofloxacin Hemihydrate is a fluoroquinolone antibiotic. It works by inhibiting bacterial topoisomerase IV and DNA gyrase, enzymes required for DNA replication, transcription, repair, and recombination. This leads to the death of the bacteria.
Uses
Levofloxacin Hemihydrate is used to treat a variety of bacterial infections, including respiratory tract infections, skin infections, urinary tract infections, and infections of the prostate gland.